EVGN Financials

Income Statement
MetricQ1 2016Q4 2015Q3 2015Q2 2015Q1 2015
Revenue
2.0M
-18.1%
2.5M
-25.6%
3.3M
+24.6%
2.7M
-1.7%
2.7M
Cost of Revenue
1.5M
-24.5%
2.0M
-19.3%
2.5M
+28.7%
1.9M
+5.6%
1.8M
Gross Profit
501.0K
+9.6%
457.0K
-44.4%
822.0K
+13.5%
724.0K
-16.9%
871.0K
Operating Expenses
5.1M
-12.7%
5.8M
+26.5%
4.6M
-14.2%
5.4M
+7.3%
5.0M
R&D
4.1M
-10.8%
4.6M
+27.2%
3.6M
-14.1%
4.2M
+3.9%
4.0M
SG&A
998.0K
-19.8%
1.2M
+24.3%
1.0M
-14.7%
1.2M
+21.9%
963.0K
Operating Income
-4584000
+14.6%
-5369000
-42.0%
-3782000
+18.5%
-4642000
-12.5%
-4128000
EBITDA
-3993000
+25.6%
-5369000
-67.8%
-3199000
+20.6%
-4030000
-16.0%
-3474000
Net Income
-3372000
+38.4%
-5472000
-61.8%
-3382000
+31.7%
-4950000
-45.2%
-3409000
EPS (Basic)
$-1.30
+40.9%
$-2.20
-69.2%
$-1.30
+35.0%
$-2.00
-53.8%
$-1.30
EPS (Diluted)
$-1.30
+40.9%
$-2.20
-69.2%
$-1.30
+35.0%
$-2.00
-53.8%
$-1.30
Shares (Diluted)
2.5M
+0.0%
2.5M
+0.0%
2.5M
+0.0%
2.5M
+0.0%
2.5M
EVOGENE (EVGN) โ€” Financials